Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2024-04-19

Clinical Trial Update: Crossover, Single Dose Randomized, Bioequivalence of Ketoprofen Lysine Salt Immediate Release vs Oral Solution [Phase 1]

View source ↗

Summary

Phase 1 trial comparing crossover bioequivalence of ketoprofen lysine salt immediate release to an oral solution; results completed with posted results.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Ketoprofen lysine salt immediate release (ketoprofen lysine salt)

Snippet

Sponsor: Dompé Farmaceutici S.p.A | Conditions: Pain Disorders | Phase 1 | Status: COMPLETED | Results posted: 2024-04-19